Home
TEM
TEM News

Latest TEMPUS AI INC (TEM) News on July 12, 2025

MT Newswires

12 days ago

Tempus AI Launches $400 Million Senior Notes Offering

Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense

Business Wire

12 days ago

Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense

Tempus AI’s Ambry Genetics Leads with Validated 99.5% Accurate Hereditary Cancer Risk Assessment Tool

Insider Monkey

12 days ago

Tempus AI’s Ambry Genetics Leads with Validated 99.5% Accurate Hereditary Cancer Risk Assessment Tool

MT Newswires

15 days ago

Danaher Names Martin Stumpe Chief Technology, AI Officer

Ambry Genetics’ CARE Program Validated for Accuracy in Identifying High-Risk Patients for Hereditary Cancer Testing

Business Wire

16 days ago

Ambry Genetics’ CARE Program Validated for Accuracy in Identifying High-Risk Patients for Hereditary Cancer Testing

Agentic AI Market worth $140.80 billion by 2032- Exclusive Report by MarketsandMarkets™

PR Newswire

17 days ago

Agentic AI Market worth $140.80 billion by 2032- Exclusive Report by MarketsandMarkets™

Tempus AI, Inc. (TEM): A Bull Case Theory

Insider Monkey

17 days ago

Tempus AI, Inc. (TEM): A Bull Case Theory

TEM vs. GH: Which AI in Precision Oncology Stock Has More Upside Now?

Zacks

19 days ago

TEM vs. GH: Which AI in Precision Oncology Stock Has More Upside Now?

Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building?

Zacks

22 days ago

Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building?

Cathie Wood's Flagship Ark Innovation ETF Is Booming Again. Here's Why.

Investor's Business Daily

23 days ago

Cathie Wood's Flagship Ark Innovation ETF Is Booming Again. Here's Why.

GuruFocus.com

23 days ago

Biovica International AB (FRA:9II) Q4 2025 Earnings Call Highlights: Strategic Partnerships and ...

Tempus to Participate in TD Cowen’s 4th Annual Tools/Dx Revolution Conference

Business Wire

25 days ago

Tempus to Participate in TD Cowen’s 4th Annual Tools/Dx Revolution Conference

Tempus AI (NasdaqGS:TEM) Soars 51% In Last Quarter

Simply Wall St.

a month ago

Tempus AI (NasdaqGS:TEM) Soars 51% In Last Quarter

Tempus AI's Expanding Ties Boost Novel R&D Efforts and Market Reach

Zacks

a month ago

Tempus AI's Expanding Ties Boost Novel R&D Efforts and Market Reach

Veteran analyst unveils bold price target for Tempus AI stock

TheStreet

a month ago

Veteran analyst unveils bold price target for Tempus AI stock

MT Newswires

a month ago

Tempus, Northwestern Collaborate on AI-Driven Alzheimer's Research

Tempus Announces Collaboration with Northwestern University’s Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer’s Disease Research

Business Wire

a month ago

Tempus Announces Collaboration with Northwestern University’s Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer’s Disease Research

Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today?

Zacks

a month ago

Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today?

Why Shares of Tempus AI Are Jumping Higher This Week

Motley Fool

a month ago

Why Shares of Tempus AI Are Jumping Higher This Week

Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape?

Zacks

a month ago

Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape?

Zacks Investment Ideas feature highlights: Tempus AI, SoundHound AI and Innodata

Zacks

a month ago

Zacks Investment Ideas feature highlights: Tempus AI, SoundHound AI and Innodata

3 AI Stocks Flying Under the Radar

Zacks

a month ago

3 AI Stocks Flying Under the Radar

Zacks Investment Ideas feature highlights: Nvidia, Alphabet, Constellation Energy and Meta Platform

Zacks

a month ago

Zacks Investment Ideas feature highlights: Nvidia, Alphabet, Constellation Energy and Meta Platform

Beyond LLMs: How Propense.ai & Tempus AI are Shaking up Legacy Industries

Zacks

a month ago

Beyond LLMs: How Propense.ai & Tempus AI are Shaking up Legacy Industries

Why Tempus AI, Inc. (TEM) Skyrocketed On Monday

Insider Monkey

a month ago

Why Tempus AI, Inc. (TEM) Skyrocketed On Monday

Why Tempus AI Stock Soared 15% Today

Motley Fool

a month ago

Why Tempus AI Stock Soared 15% Today

Investing.com

a month ago

Tempus AI recovers 15% as Wall Street downplays Spruce Point allegations

Tempus AI rebound, Meta's AI ad push, Broadcom earnings optimism

Yahoo Finance Video

a month ago

Tempus AI rebound, Meta's AI ad push, Broadcom earnings optimism

Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers

Business Wire

a month ago

Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers

Cathie Wood buys $13.9 million of popular AI stock

TheStreet

a month ago

Cathie Wood buys $13.9 million of popular AI stock

Introducing Tempus One in the EHR with Integrated Guidelines

Business Wire

a month ago

Introducing Tempus One in the EHR with Integrated Guidelines

Tempus AI hits back at scathing short report

TheStreet

a month ago

Tempus AI hits back at scathing short report

Tempus AI announces 10 abstracts accepted for presentation at 2025 ASCO meeting

TipRanks

a month ago

Tempus AI announces 10 abstracts accepted for presentation at 2025 ASCO meeting

Tempus Introduces Fuses, A Program Designed to Transform Therapeutic Research and Build the Largest Diagnostic Platform Using its Novel Foundation Model

Business Wire

a month ago

Tempus Introduces Fuses, A Program Designed to Transform Therapeutic Research and Build the Largest Diagnostic Platform Using its Novel Foundation Model

Why Tempus AI Stock Plummeted This Week

Motley Fool

a month ago

Why Tempus AI Stock Plummeted This Week

Tempus Announces 10 Abstracts Accepted for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting

Business Wire

a month ago

Tempus Announces 10 Abstracts Accepted for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting

Why Tempus AI, Inc. (TEM) Went Down On Wednesday

Insider Monkey

a month ago

Why Tempus AI, Inc. (TEM) Went Down On Wednesday

Tempus AI, Box earnings, Victoria's Secret: Trending Tickers

Yahoo Finance Video

a month ago

Tempus AI, Box earnings, Victoria's Secret: Trending Tickers

A Cathie Wood Favorite Is Falling: Why Tempus AI Stock Is Imploding Today

Motley Fool

a month ago

A Cathie Wood Favorite Is Falling: Why Tempus AI Stock Is Imploding Today

Nvidia earnings, Tempus AI short, Vail Resorts CEO returns

Yahoo Finance Video

a month ago

Nvidia earnings, Tempus AI short, Vail Resorts CEO returns

Why Artificial Intelligence Stock Tempus AI Is Tumbling Today

Motley Fool

a month ago

Why Artificial Intelligence Stock Tempus AI Is Tumbling Today

MT Newswires

a month ago

Tempus AI Shares Fall After Short Seller Spruce Point Raises Concerns About Management, AI Capabilities

A Decade of Discovery: Tempus Supported Almost 1,500 Research Projects in 10 Years

Business Wire

a month ago

A Decade of Discovery: Tempus Supported Almost 1,500 Research Projects in 10 Years

New Study Shows Impact of Ambry Genetics’ Patient for Life™ Program on Rare Disease Diagnosis

Business Wire

a month ago

New Study Shows Impact of Ambry Genetics’ Patient for Life™ Program on Rare Disease Diagnosis

Tempus AI vs. Butterfly: Which AI Health Tech Stock is the Better Buy?

Zacks

2 months ago

Tempus AI vs. Butterfly: Which AI Health Tech Stock is the Better Buy?

Despite selling recently, Tempus AI, Inc. (NASDAQ:TEM) insiders own 41% stake and recent decline might have cost them

Simply Wall St.

2 months ago

Despite selling recently, Tempus AI, Inc. (NASDAQ:TEM) insiders own 41% stake and recent decline might have cost them

These Investors Search for ‘Extreme Winners.’ Why Aurora, BYD, Tempus AI Make the Cut.

Barrons.com

2 months ago

These Investors Search for ‘Extreme Winners.’ Why Aurora, BYD, Tempus AI Make the Cut.

Options Trading Now Available on Three Tradr ETFs: QBTX, TEMT and APPX

PR Newswire

2 months ago

Options Trading Now Available on Three Tradr ETFs: QBTX, TEMT and APPX

Zacks Investment Ideas feature highlights: Palantir, Tempus AI and Comfort Systems USA

Zacks

2 months ago

Zacks Investment Ideas feature highlights: Palantir, Tempus AI and Comfort Systems USA

Tempus to Present at the William Blair 45th Annual Growth Stock Conference

Business Wire

2 months ago

Tempus to Present at the William Blair 45th Annual Growth Stock Conference

Tempus partners with Verastem for companion diagnostic development

Medical Device Network

2 months ago

Tempus partners with Verastem for companion diagnostic development

MT Newswires

2 months ago

Tempus AI, Verastem to Develop Diagnostic Test for Ovarian Cancer Combination Treatment

Tempus Announces a Collaboration with Verastem to Develop CDx for First-Ever FDA-Approved KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer Combination Treatment

Business Wire

2 months ago

Tempus Announces a Collaboration with Verastem to Develop CDx for First-Ever FDA-Approved KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer Combination Treatment

Should You be Confident in Tempus AI (TEM)?

Insider Monkey

2 months ago

Should You be Confident in Tempus AI (TEM)?

After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order?

Zacks

2 months ago

After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order?

Boehringer partners Tempus AI to enhance cancer therapy pipeline

Pharmaceutical Technology

2 months ago

Boehringer partners Tempus AI to enhance cancer therapy pipeline

MT Newswires

2 months ago

Tempus AI Enters Collaboration With Boehringer Ingelheim to Advance Boehringer's Cancer Pipeline

Tempus Enters Multi-Year Strategic Collaboration With Boehringer Ingelheim to Advance Its Cancer Pipeline

Business Wire

2 months ago

Tempus Enters Multi-Year Strategic Collaboration With Boehringer Ingelheim to Advance Its Cancer Pipeline

Why Tempus AI Inc. (TEM) Skyrocketed On Tuesday

Insider Monkey

2 months ago

Why Tempus AI Inc. (TEM) Skyrocketed On Tuesday

Tempus Announces Six Posters Accepted for Presentation at ISPOR 2025

Business Wire

2 months ago

Tempus Announces Six Posters Accepted for Presentation at ISPOR 2025

Is Tempus AI, Inc. (TEM) the Best Performing Healthcare Stock to Buy Now?

Insider Monkey

2 months ago

Is Tempus AI, Inc. (TEM) the Best Performing Healthcare Stock to Buy Now?

Tradr Launches First Leveraged ETF on Tempus AI

PR Newswire

2 months ago

Tradr Launches First Leveraged ETF on Tempus AI

Jim Cramer Says Stay Away from This Nancy Pelosi Stock

Insider Monkey

2 months ago

Jim Cramer Says Stay Away from This Nancy Pelosi Stock

Why Tempus AI, Inc. (TEM) Skyrocketed On Wednesday

Insider Monkey

2 months ago

Why Tempus AI, Inc. (TEM) Skyrocketed On Wednesday

Thomson Reuters StreetEvents

2 months ago

Q1 2025 Tempus AI Inc Earnings Call

Tempus AI, Inc. (TEM): Among Most Popular Stocks on Robinhood in 2025

Insider Monkey

2 months ago

Tempus AI, Inc. (TEM): Among Most Popular Stocks on Robinhood in 2025

GuruFocus.com

2 months ago

Tempus AI Inc (TEM) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...

MT Newswires

2 months ago

Tempus AI Q1 Non-GAAP Loss Narrows; Revenue Rises; Slightly Ups Full Year Guidance

Tempus Reports First Quarter 2025 Results

Business Wire

2 months ago

Tempus Reports First Quarter 2025 Results

Jim Cramer Warns on Tempus AI (TEM): “Diagnostics With no Dough? I’m Out”

Insider Monkey

2 months ago

Jim Cramer Warns on Tempus AI (TEM): “Diagnostics With no Dough? I’m Out”

Tempus Announces Notetaker, its AI-Powered Clinical Assistant for Psychiatry

Business Wire

2 months ago

Tempus Announces Notetaker, its AI-Powered Clinical Assistant for Psychiatry

Think It's Too Late to Buy Tempus AI? Here's the Biggest Reason Why There's Still Time.

Motley Fool

2 months ago

Think It's Too Late to Buy Tempus AI? Here's the Biggest Reason Why There's Still Time.

Tempus selects TIME Network for Phase I clinical trials

Clinical Trials Arena

2 months ago

Tempus selects TIME Network for Phase I clinical trials

Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment

Business Wire

2 months ago

Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment

Tempus Publishes Study Validating the Benefits of xF+, its Comprehensive Liquid Biopsy Assay for Therapy Selection

Business Wire

2 months ago

Tempus Publishes Study Validating the Benefits of xF+, its Comprehensive Liquid Biopsy Assay for Therapy Selection

Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings?

Zacks

2 months ago

Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings?

Tempus Introduces Loop, an AI-Powered Target Discovery and Validation Platform

Business Wire

2 months ago

Tempus Introduces Loop, an AI-Powered Target Discovery and Validation Platform

Why Tempus AI Inc. (TEM) Soared Last Week

Insider Monkey

3 months ago

Why Tempus AI Inc. (TEM) Soared Last Week

Tempus Announces 18 Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025

Business Wire

3 months ago

Tempus Announces 18 Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025

The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS

Zacks

3 months ago

The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS

Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal?

Zacks

3 months ago

Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal?

Tempus to Report First Quarter 2025 Financial Results on May 6

Business Wire

3 months ago

Tempus to Report First Quarter 2025 Financial Results on May 6

AstraZeneca enters $200m AI cancer pact with Tempus and Pathos

Pharmaceutical Technology

3 months ago

AstraZeneca enters $200m AI cancer pact with Tempus and Pathos

Tempus AI, Inc. (TEM): A Bull Case Theory

Insider Monkey

3 months ago

Tempus AI, Inc. (TEM): A Bull Case Theory

Why Tempus AI Inc. (TEM) Went Up On Wednesday

Insider Monkey

3 months ago

Why Tempus AI Inc. (TEM) Went Up On Wednesday

MT Newswires

3 months ago

Sector Update: Health Care Stocks Edge Up Late Afternoon

Tempus AI Is Skyrocketing Today -- Is the Stock a Buy Right Now?

Motley Fool

3 months ago

Tempus AI Is Skyrocketing Today -- Is the Stock a Buy Right Now?

Is Tempus AI, Inc. (TEM) the Best Nancy Pelosi Stock To Invest In Now?

Insider Monkey

3 months ago

Is Tempus AI, Inc. (TEM) the Best Nancy Pelosi Stock To Invest In Now?

Why Tempus AI Stock Is Skyrocketing Today

Motley Fool

3 months ago

Why Tempus AI Stock Is Skyrocketing Today

MT Newswires

3 months ago

Tempus AI to Build Oncology Multimodal Foundation Model in Partnership With AstraZeneca, Pathos AI

Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology

Business Wire

3 months ago

Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology

Tempus AI (TEM) Initiated at ‘Buy’ with $60 Price Target by BTIG

Insider Monkey

3 months ago

Tempus AI (TEM) Initiated at ‘Buy’ with $60 Price Target by BTIG

Tempus AI Gets Bullish Boost from BTIG on Data Strength, Expansion Moves

GuruFocus.com

3 months ago

Tempus AI Gets Bullish Boost from BTIG on Data Strength, Expansion Moves

MT Newswires

3 months ago

BTIG Initiates Tempus AI at Buy With $60 Price Target

Tempus Unveils Advisory Board Featuring Leading Physicians From Across the U.S.

Business Wire

3 months ago

Tempus Unveils Advisory Board Featuring Leading Physicians From Across the U.S.

Illumina, Tempus AI partner to drive genomic testing beyond cancer

MedTech Dive

3 months ago

Illumina, Tempus AI partner to drive genomic testing beyond cancer

MT Newswires

3 months ago

Illumina, Tempus AI Collaborating to Accelerate Clinical Use of Sequencing Tests

Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation

PR Newswire

3 months ago

Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation

Tempus AI vs. Doximity: Which AI in Healthcare Stock is a Better Buy?

Zacks

3 months ago

Tempus AI vs. Doximity: Which AI in Healthcare Stock is a Better Buy?

Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025

Zacks

3 months ago

Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025

Share on Social Networks: